Prof. M.-Pilar Marco
@mpilarmarco1
Professor of Research CSIC
ID: 355521158
http://www.iqac.csic.es/nb4d/ 15-08-2011 13:54:45
1,1K Tweet
255 Followers
367 Following
Join the 5th European Biosensor Symposium EuroBiosens in Tarragona and listen the latest advances in the field. We are proud to count with excellent speakers such as John A Rogers from Northwestern University Northwestern Uni. Institute for Advanced Chemistry of Catalonia. instagram.com/p/DG_QtdDN5cO/…
🎓 New doctor in the room! 👩🔬 Carla Ferrero got her PhD last 25th April. "Quorum Sensing as a Potential Biomarker Target to Diagnose Staphylococcus aureus Infections", supervised by Prof. M.-Pilar Marco and J.-Pablo Salvador 🎖️ Excellent presentation, outstanding defense. Congrats Carla!
📰 New publication! 😍Top review entitled "Analysing the integrated quorum sensing (iqs) system and its potential role in Pseudomonas aeruginosa pathogenesis" by Juan Raya, Enrique J. Montagut, Prof. M.-Pilar Marco ➡️frontiersin.org/journals/cellu…
Professor Paul Yager from WU Bioengineering (UW Bioengineering) will be joining EBS2025 (EuroBiosens)! He has been a pioneer in using paper and accessible materials to create rapid diagnostic technologies. Register now and have the chance to meet him and many other scellent scientits.
We are glad to have Professor Josep Samitier from IBEC participating in the next EuroBiosens 2025 Symposium. He is a prominent figure in Catalonia's scientific landscape, particularly in the fields of nanotechnology and bioengineering. Nb4D; Institute for Advanced Chemistry of Catalonia
Great news! Our diagnostic kit for infectious diseases has been selected by CSIC Innovación under the IMPULSA-T program. We’re deeply grateful to CSIC. This recognition inspires us to continue driving innovation for the well-being of society. csic.es/es/actualidad-…
We’re honored to have QS4Dx recognized in the Entrepreneurship category at the II CSIC Transfer and Entrepreneurship Awards. Thanks to CSIC Innovación! it inspires us to keep pushing forward with innovative diagnostics for a healthier society. csic.es/es/actualidad-…
Instituto de Salud Carlos III (ISCIII) Prof. M.-Pilar Marco CSIC AEMPS Hospital Clínic Queen's University Belfast 🎓 Amgen 🧪🔬🧬 #BIOSPAIN2025 | Clinical translation often applies HTA too late, limiting its impact on early-stage development. Early HTA aligns research with real-world needs and maximizes patient benefit.
Instituto de Salud Carlos III (ISCIII) Prof. M.-Pilar Marco CSIC AEMPS Hospital Clínic Queen's University Belfast 🎓 Amgen 🧪🔬🧬 #BIOSPAIN2025 | Prof. M.-Pilar Marco, Professor Of Research, CSIC, explains that involving stakeholders, including patients and healthcare professionals assure that innovations are relevant for the clinical practice.
Instituto de Salud Carlos III (ISCIII) Prof. M.-Pilar Marco CSIC AEMPS Hospital Clínic Queen's University Belfast 🎓 Amgen 🧪🔬🧬 #BIOSPAIN2025 | María José del Pino, National Representative & Clinical Evaluator, AEMPS, states that taking into account aspects like the safety and efficacy in between medicines is going to be done in an harmonized way with all the HTA bodies working together.
At the end of October, the 5th edition of EuroBiosens will take place in #Tarragona, organized by Prof. M.-Pilar Marco and Nb4D — a key event in biosensing technology bringing together experts from all sectors. 👉 ebs2025.com